Fibrosis worsens chronic lymphedema in rodent tissues.
Identifieur interne : 000F90 ( PubMed/Curation ); précédent : 000F89; suivant : 000F91Fibrosis worsens chronic lymphedema in rodent tissues.
Auteurs : Laura L. Lynch [États-Unis] ; Uziel Mendez [États-Unis] ; Anna B. Waller [États-Unis] ; Amani A. Gillette [États-Unis] ; Roger J. Guillory [États-Unis] ; Jeremy Goldman [États-Unis]Source :
- American journal of physiology. Heart and circulatory physiology [ 1522-1539 ] ; 2015.
Descripteurs français
- KwdFr :
- Animaux, Bléomycine (toxicité), Femelle, Fibrose (anatomopathologie), Fibrose (physiopathologie), Fibrose (étiologie), Inflammation (anatomopathologie), Inflammation (physiopathologie), Lymphadénectomie (effets indésirables), Lymphoedème (anatomopathologie), Lymphoedème (physiopathologie), Rat Sprague-Dawley, Rats, Souris, Souris de lignée BALB C, Système lymphatique (), Système lymphatique (anatomopathologie), Système lymphatique (physiopathologie).
- MESH :
- anatomopathologie : Fibrose, Inflammation, Lymphoedème, Système lymphatique.
- effets indésirables : Lymphadénectomie.
- physiopathologie : Fibrose, Inflammation, Lymphoedème, Système lymphatique.
- toxicité : Bléomycine.
- étiologie : Fibrose.
- Animaux, Femelle, Rat Sprague-Dawley, Rats, Souris, Souris de lignée BALB C, Système lymphatique.
English descriptors
- KwdEn :
- Animals, Bleomycin (toxicity), Female, Fibrosis (etiology), Fibrosis (pathology), Fibrosis (physiopathology), Inflammation (pathology), Inflammation (physiopathology), Lymph Node Excision (adverse effects), Lymphatic System (drug effects), Lymphatic System (pathology), Lymphatic System (physiopathology), Lymphedema (pathology), Lymphedema (physiopathology), Mice, Mice, Inbred BALB C, Rats, Rats, Sprague-Dawley.
- MESH :
- chemical , toxicity : Bleomycin.
- adverse effects : Lymph Node Excision.
- drug effects : Lymphatic System.
- etiology : Fibrosis.
- pathology : Fibrosis, Inflammation, Lymphatic System, Lymphedema.
- physiopathology : Fibrosis, Inflammation, Lymphatic System, Lymphedema.
- Animals, Female, Mice, Mice, Inbred BALB C, Rats, Rats, Sprague-Dawley.
Abstract
Secondary lymphedema in humans is a common consequence of lymph node dissection (LND) to treat breast cancer. A peculiar characteristic of the disease is that lifelong swelling often precipitously appears several years after the surgical treatment, often due to an inflammatory stimulus. Although the incidence of secondary lymphedema dramatically increases after radiation therapy, the relationship between fibrotic scarring and the eventual appearance of lymphedema remains unclear. To clarify the role of fibrosis in secondary lymphedema initiation, we chemically increased fibrosis in rodent tissues with bleomycin and assessed the ability of the local lymphatic system to prevent lymphedema, either acutely or in a chronic state induced by inflammation. We found that bleomycin injections exacerbated fibrotic matrix deposition in an acute mouse tail lymphedema model (P < 0.005), reduced wound closure (P < 0.005), and impaired the ability of tail lymphatics to regenerate (P < 0.005) and reduce the swelling (P < 0.05). When fibrosis was worsened with bleomycin after axillary LND in the rat foreleg, the ability of the foreleg lymphatic system to reduce the chronic state swelling induced by stimulated inflammation was severely impaired (P < 0.005). Indocyanine green lymphography in axillary LND-recovered rat forelegs revealed a worsened lymphatic drainage due to inflammation and bleomycin pretreatment. Although inflammation reduced the drainage of dextran fluid tracer from control forelegs (P < 0.05), the reduction in fluid drainage was more severe after axillary LND when fibrosis was first increased (P < 0.005). These findings demonstrate that fibrosis reduces the lymphatic capacity to functionally regenerate and prevent the chronic appearance of lymphedema.
DOI: 10.1152/ajpheart.00527.2013
PubMed: 25770241
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F90
Links to Exploration step
pubmed:25770241Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fibrosis worsens chronic lymphedema in rodent tissues.</title>
<author><name sortKey="Lynch, Laura L" sort="Lynch, Laura L" uniqKey="Lynch L" first="Laura L" last="Lynch">Laura L. Lynch</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Waller, Anna B" sort="Waller, Anna B" uniqKey="Waller A" first="Anna B" last="Waller">Anna B. Waller</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Gillette, Amani A" sort="Gillette, Amani A" uniqKey="Gillette A" first="Amani A" last="Gillette">Amani A. Gillette</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guillory, Roger J" sort="Guillory, Roger J" uniqKey="Guillory R" first="Roger J" last="Guillory">Roger J. Guillory</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan jgoldman@mtu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25770241</idno>
<idno type="pmid">25770241</idno>
<idno type="doi">10.1152/ajpheart.00527.2013</idno>
<idno type="wicri:Area/PubMed/Corpus">000F90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F90</idno>
<idno type="wicri:Area/PubMed/Curation">000F90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F90</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Fibrosis worsens chronic lymphedema in rodent tissues.</title>
<author><name sortKey="Lynch, Laura L" sort="Lynch, Laura L" uniqKey="Lynch L" first="Laura L" last="Lynch">Laura L. Lynch</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Waller, Anna B" sort="Waller, Anna B" uniqKey="Waller A" first="Anna B" last="Waller">Anna B. Waller</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Gillette, Amani A" sort="Gillette, Amani A" uniqKey="Gillette A" first="Amani A" last="Gillette">Amani A. Gillette</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guillory, Roger J" sort="Guillory, Roger J" uniqKey="Guillory R" first="Roger J" last="Guillory">Roger J. Guillory</name>
<affiliation wicri:level="2"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan jgoldman@mtu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Biomedical Engineering Department, Michigan Technological University, Houghton</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of physiology. Heart and circulatory physiology</title>
<idno type="eISSN">1522-1539</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Bleomycin (toxicity)</term>
<term>Female</term>
<term>Fibrosis (etiology)</term>
<term>Fibrosis (pathology)</term>
<term>Fibrosis (physiopathology)</term>
<term>Inflammation (pathology)</term>
<term>Inflammation (physiopathology)</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphatic System (drug effects)</term>
<term>Lymphatic System (pathology)</term>
<term>Lymphatic System (physiopathology)</term>
<term>Lymphedema (pathology)</term>
<term>Lymphedema (physiopathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Bléomycine (toxicité)</term>
<term>Femelle</term>
<term>Fibrose (anatomopathologie)</term>
<term>Fibrose (physiopathologie)</term>
<term>Fibrose (étiologie)</term>
<term>Inflammation (anatomopathologie)</term>
<term>Inflammation (physiopathologie)</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Rat Sprague-Dawley</term>
<term>Rats</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Système lymphatique ()</term>
<term>Système lymphatique (anatomopathologie)</term>
<term>Système lymphatique (physiopathologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en"><term>Bleomycin</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Fibrose</term>
<term>Inflammation</term>
<term>Lymphoedème</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Fibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Fibrosis</term>
<term>Inflammation</term>
<term>Lymphatic System</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Fibrose</term>
<term>Inflammation</term>
<term>Lymphoedème</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Fibrosis</term>
<term>Inflammation</term>
<term>Lymphatic System</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="toxicité" xml:lang="fr"><term>Bléomycine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Fibrose</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Female</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Rat Sprague-Dawley</term>
<term>Rats</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Système lymphatique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Secondary lymphedema in humans is a common consequence of lymph node dissection (LND) to treat breast cancer. A peculiar characteristic of the disease is that lifelong swelling often precipitously appears several years after the surgical treatment, often due to an inflammatory stimulus. Although the incidence of secondary lymphedema dramatically increases after radiation therapy, the relationship between fibrotic scarring and the eventual appearance of lymphedema remains unclear. To clarify the role of fibrosis in secondary lymphedema initiation, we chemically increased fibrosis in rodent tissues with bleomycin and assessed the ability of the local lymphatic system to prevent lymphedema, either acutely or in a chronic state induced by inflammation. We found that bleomycin injections exacerbated fibrotic matrix deposition in an acute mouse tail lymphedema model (P < 0.005), reduced wound closure (P < 0.005), and impaired the ability of tail lymphatics to regenerate (P < 0.005) and reduce the swelling (P < 0.05). When fibrosis was worsened with bleomycin after axillary LND in the rat foreleg, the ability of the foreleg lymphatic system to reduce the chronic state swelling induced by stimulated inflammation was severely impaired (P < 0.005). Indocyanine green lymphography in axillary LND-recovered rat forelegs revealed a worsened lymphatic drainage due to inflammation and bleomycin pretreatment. Although inflammation reduced the drainage of dextran fluid tracer from control forelegs (P < 0.05), the reduction in fluid drainage was more severe after axillary LND when fibrosis was first increased (P < 0.005). These findings demonstrate that fibrosis reduces the lymphatic capacity to functionally regenerate and prevent the chronic appearance of lymphedema.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25770241</PMID>
<DateCreated><Year>2015</Year>
<Month>05</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>07</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1539</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>308</Volume>
<Issue>10</Issue>
<PubDate><Year>2015</Year>
<Month>May</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Heart and circulatory physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Heart Circ. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fibrosis worsens chronic lymphedema in rodent tissues.</ArticleTitle>
<Pagination><MedlinePgn>H1229-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpheart.00527.2013</ELocationID>
<Abstract><AbstractText>Secondary lymphedema in humans is a common consequence of lymph node dissection (LND) to treat breast cancer. A peculiar characteristic of the disease is that lifelong swelling often precipitously appears several years after the surgical treatment, often due to an inflammatory stimulus. Although the incidence of secondary lymphedema dramatically increases after radiation therapy, the relationship between fibrotic scarring and the eventual appearance of lymphedema remains unclear. To clarify the role of fibrosis in secondary lymphedema initiation, we chemically increased fibrosis in rodent tissues with bleomycin and assessed the ability of the local lymphatic system to prevent lymphedema, either acutely or in a chronic state induced by inflammation. We found that bleomycin injections exacerbated fibrotic matrix deposition in an acute mouse tail lymphedema model (P < 0.005), reduced wound closure (P < 0.005), and impaired the ability of tail lymphatics to regenerate (P < 0.005) and reduce the swelling (P < 0.05). When fibrosis was worsened with bleomycin after axillary LND in the rat foreleg, the ability of the foreleg lymphatic system to reduce the chronic state swelling induced by stimulated inflammation was severely impaired (P < 0.005). Indocyanine green lymphography in axillary LND-recovered rat forelegs revealed a worsened lymphatic drainage due to inflammation and bleomycin pretreatment. Although inflammation reduced the drainage of dextran fluid tracer from control forelegs (P < 0.05), the reduction in fluid drainage was more severe after axillary LND when fibrosis was first increased (P < 0.005). These findings demonstrate that fibrosis reduces the lymphatic capacity to functionally regenerate and prevent the chronic appearance of lymphedema.</AbstractText>
<CopyrightInformation>Copyright © 2015 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName>
<ForeName>Laura L</ForeName>
<Initials>LL</Initials>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mendez</LastName>
<ForeName>Uziel</ForeName>
<Initials>U</Initials>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Waller</LastName>
<ForeName>Anna B</ForeName>
<Initials>AB</Initials>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gillette</LastName>
<ForeName>Amani A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guillory</LastName>
<ForeName>Roger J</ForeName>
<Initials>RJ</Initials>
<Suffix>2nd</Suffix>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Goldman</LastName>
<ForeName>Jeremy</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Biomedical Engineering Department, Michigan Technological University, Houghton, Michigan jgoldman@mtu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R15-HL-113954</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>03</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Physiol Heart Circ Physiol</MedlineTA>
<NlmUniqueID>100901228</NlmUniqueID>
<ISSNLinking>0363-6135</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>11056-06-7</RegistryNumber>
<NameOfSubstance UI="D001761">Bleomycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C392-404</RefSource>
<PMID Version="1">21940662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2007 Sep;40(3):122-6</RefSource>
<PMID Version="1">18062613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2798-802</RefSource>
<PMID Version="1">9874400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jan 17;93(2):96-111</RefSource>
<PMID Version="1">11208879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2176-83</RefSource>
<PMID Version="1">17189348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1326-34</RefSource>
<PMID Version="1">18203849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1986 Jul;73(7):580-4</RefSource>
<PMID Version="1">3730795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2013 Jun;11(2):72-5</RefSource>
<PMID Version="1">23772716</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2013 Mar;27(3):1114-26</RefSource>
<PMID Version="1">23193171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H46-54</RefSource>
<PMID Version="1">20207821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2008 Nov;44(17):2587-99</RefSource>
<PMID Version="1">18757193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2003 Apr 18;92(7):801-8</RefSource>
<PMID Version="1">12623882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 2007 Jun;58(6):652-5</RefSource>
<PMID Version="1">17522489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2004 Jun;11(6):573-80</RefSource>
<PMID Version="1">15172932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 2007 Aug;59(2):180-4</RefSource>
<PMID Version="1">17667413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2009 Aug;124(2):438-50</RefSource>
<PMID Version="1">19644258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource>
<PMID Version="1">21056998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2012 Nov 1;303(9):H1107-13</RefSource>
<PMID Version="1">22942182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2007 Dec;13(12):1458-66</RefSource>
<PMID Version="1">18059280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2013 May-Jun;19(3):250-8</RefSource>
<PMID Version="1">23614363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 2007 Jul;59(1):41-5</RefSource>
<PMID Version="1">17589258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vasc Surg. 2007 May;45(5):1016-21</RefSource>
<PMID Version="1">17391894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pathophysiology. 2010 Sep;17(4):289-94</RefSource>
<PMID Version="1">19963358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2010 Sep;299(3):C589-605</RefSource>
<PMID Version="1">20519446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiology. 2008 Mar;246(3):734-41</RefSource>
<PMID Version="1">18223125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Cancer Drug Targets. 2009 May;9(3):341-53</RefSource>
<PMID Version="1">19442053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27</RefSource>
<PMID Version="1">18849330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3109-18</RefSource>
<PMID Version="1">17307997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2012 Jun 1;302(11):H2250-6</RefSource>
<PMID Version="1">22427513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2012 Mar;26(3):1027-39</RefSource>
<PMID Version="1">22067482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fed Proc. 1976 Jun;35(8):1863-71</RefSource>
<PMID Version="1">1269772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 1997 Dec;30(4):194-202</RefSource>
<PMID Version="1">9476251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1983 Dec;9(12):1807-13</RefSource>
<PMID Version="1">6662749</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001761" MajorTopicYN="N">Bleomycin</DescriptorName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4436986</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">axillary lymph node dissection</Keyword>
<Keyword MajorTopicYN="N">chronic secondary lymphedema</Keyword>
<Keyword MajorTopicYN="N">inflammation</Keyword>
<Keyword MajorTopicYN="N">lymphangiogenesis</Keyword>
<Keyword MajorTopicYN="N">lymphatic drainage</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>07</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>03</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25770241</ArticleId>
<ArticleId IdType="pii">ajpheart.00527.2013</ArticleId>
<ArticleId IdType="doi">10.1152/ajpheart.00527.2013</ArticleId>
<ArticleId IdType="pmc">PMC4436986</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000F90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25770241 |texte= Fibrosis worsens chronic lymphedema in rodent tissues. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25770241" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |